期刊
CHEMICAL RESEARCH IN TOXICOLOGY
卷 30, 期 8, 页码 1629-1640出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.chemrestox.7b00131
关键词
-
资金
- Association pour la Recherche sur le Cancer (ARC grant) [4835]
- EU-COST action [CM1105]
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- CNRS (Centre National de la Recherche Scientifique)
Telomeres protect the ends of chroniosonies against illegitimate recombination and repair. They can be targets for G-quadruplex ligands and platinum complexes due to their repeated G-rich sequences. Protection of telomeres is ensured by a complex of six proteins, including TRF2, which inhibits the DNA damage response pathway. We analyzed telomere modifications induced in cancer cells by the experimental hybrid platinum complex, Pt-MPQ, comprising both an ethylene diamine monofunctional platinum complex and a G-quadruplex recognition moiety (MPQ). Pt-MPQ promotes the displacement of-two telometic proteins (TRF2 and TRF1) from telomeres, as well as the formation of telomere damage and telomere sister losses, whereas the control compound MPQ of does not. This suggests that the platinum moiety potentiates the targeting of the G-quadruplex ligand to telomeres, opening a new perspective for telomere biology and anticancer therapy. Interestingly, the chemotherapy drug cisplatini which has no specific affinity for G-quadruplex structures, partially induces the TRF2 delocalization from telomeres but produces less telomeric DNA damage, suggesting that this TRF2 displacement could be independent of G-quadruplex recognition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据